Login / Signup

Treatment resistant impetigo herpetiformis treated with infliximab.

Atiye OgrumZennure TakciHavva Yildiz SeckinElif Cetin
Published in: Dermatologic therapy (2019)
Impetigo herpetiformis is a rare disease of pregnancy with the onset being in the second half of pregnancy and resolution after delivery. It is associated with a high rate of perinatal mortality and fetal abnormalities. Clinical and histological features of the disease are consistent with pustuler psoriasis. We reported a case of 25-year-old female gravida 1 para 0, who responded poorly to consecutive treatments with systemic steroids, cyclosporine, intravenous immunoglobulin, and acitretin. Good response was obtained with adding infliximab to the treatment.
Keyphrases
  • preterm birth
  • ulcerative colitis
  • pregnancy outcomes
  • pregnant women
  • high dose
  • cardiovascular events
  • low dose
  • combination therapy
  • coronary artery disease
  • newly diagnosed
  • atopic dermatitis